用普罗波进行缓解性镇静,用于耐火性激发
Kelvin Lou1, Brian Li2, Shikha Minhas2
1The University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada klou@alumni.ubc.ca.
BMJ supportive & palliative care
|May 2, 2025
概括
息镇静有效地管理生命末期的症状. 在标准治疗失败时,Propofol为耐火病例提供了一种有价值的选择,提高了患者的舒适度.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 息镇静对于在终身护理中管理耐药症状至关重要.
- 有限的研究存在于对抗标准镇静方案的症状的管理.
- 有效的症状管理对于患者的舒适性和生活质量至关重要.
研究的目的:
- 在息治疗中探索耐火性症状的治疗选择.
- 突出普罗波在管理难以治疗的症状方面的潜力.
- 提出一个案例研究,证明普罗波福在息镇静中有效.
主要方法:
- 一个40岁的女性患有转移性卵巢癌的病例报告.
- 使用息镇静的propofol进行耐火激动的管理.
- 评估症状缓解和治疗有效性的评估.
主要成果:
- 普罗波在患者中成功管理了耐火性激动.
- 高剂量的常规镇静剂不足以缓解症状.
- 使用普罗波福尔的息镇静提供了足够的症状控制.
结论:
- 普罗波在耐火病例中是一种潜在的有价值的缓解镇静剂.
- 扩大对治疗选择的知识可以改善终身症状管理.
- 这个案例说明了当标准协议失败时,成功使用propofol.
相关概念视频
Parenteral Anesthetics: Overview
82
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
82
Sedatives and Hypnotics Drugs: Miscellaneous Agents
97
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
97
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
179
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
179
Skeletal Muscle Relaxants: Adverse Effects
309
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
309
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
143
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
143
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148


